SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Perrine Roux, Lionel Fugon, Maria Winnock, Dominique Salmon-Céron, Karine Lacombe, Philippe Sogni, Bruno Spire, François Dabis, Maria Patrizia Carrieri, Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus–HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users, Addiction, 2012, 107, 1
  2. 2
    EASL Clinical Practice Guidelines: Management of hepatitis C virus infection, Journal of Hepatology, 2011, 55, 2, 245

    CrossRef

  3. 3
    Mohsen Malekinejad, Mohsen Vazirian, Transition to injection amongst opioid users in Iran: Implications for harm reduction, International Journal of Drug Policy, 2011,

    CrossRef

  4. 4
    Uriel R. Felsen, Dawn A. Fishbein, Alain H. Litwin, Low Rates of Hepatitis A and B Vaccination in Patients with Chronic Hepatitis C at an Urban Methadone Maintenance Program, Journal of Addictive Diseases, 2010, 29, 4, 461

    CrossRef

  5. 5
    Jason Grebely, Elizabeth Knight, Krista A. Genoway, Mark Viljoen, Milan Khara, Doug Elliott, Lesley Gallagher, Michelle Storms, Jesse D. Raffa, Stanley DeVlaming, Fiona Duncan, Brian Conway, Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support, European Journal of Gastroenterology & Hepatology, 2010, 22, 3, 270

    CrossRef

  6. 6
    Jason Grebely, Elizabeth Knight, Tyler Ngai, Krista A Genoway, Jesse D Raffa, Michelle Storms, Lesley Gallagher, Mel Krajden, Gregory J Dore, Fiona Duncan, Brian Conway, Reinfection with hepatitis C virus following sustained virological response in injection drug users, Journal of Gastroenterology and Hepatology, 2010, 25, 7
  7. 7
    Spilios Manolakopoulos, Melanie J. Deutsch, Olga Anagnostou, Stelios Karatapanis, Elli Tiniakou, George V. Papatheodoridis, Ekaterini Georgiou, Emmanuel Manesis, Dimitris Tzourmakliotis, Athanasios J. Archimandritis, Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C, Liver International, 2010, 30, 10
  8. 8
    STUART C. RAY, DAVID L. THOMAS, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

  9. 9
    Timothy W. Kinlock, Michael S. Gordon, Robert P. Schwartz, Terrence T. Fitzgerald, Kevin E. O'Grady, A randomized clinical trial of methadone maintenance for prisoners: Results at 12 months postrelease, Journal of Substance Abuse Treatment, 2009, 37, 3, 277

    CrossRef

  10. 10
    Dimitrios Dimitroulopoulos, Elefteria Petroulaki, Spilios Manolakopoulos, Olga Anagnostou, Domna Tsaklakidou, Dimitrios Xinopoulos, Klisthenis Tsamakidis, Dimitrios Tzourmakliotis, Emmanouel Paraskevas, Peginterferon/ribavirin treatment achieves a higher compliance rate than interferon/ribavirin combination in patients chronically infected with HCV on methadone maintenance, European Journal of Gastroenterology & Hepatology, 2009, 21, 12, 1407

    CrossRef

  11. 11
    Rosa Quelhas, Alice Lopes, Psychiatric Problems in Patients Infected with Hepatitis C Before and During Antiviral Treatment with Interferon-Alpha: A Review, Journal of Psychiatric Practice, 2009, 15, 4, 262

    CrossRef

  12. 12
    Glenn Wagner, Gery Ryan, Karen Chan Osilla, Laveeza Bhatti, Matthew Goetz, Mallory Witt, Treat Early or Wait and Monitor? A Qualitative Analysis of Provider Hepatitis C Virus Treatment Decision-Making in the Context of HIV Coinfection, AIDS Patient Care and STDs, 2009, 23, 9, 715

    CrossRef

  13. 13
    Laurent Michel, Jean-Philippe Lang, Pascal Melin, Psychiatrie, VIH et hépatite C, 2009,

    CrossRef

  14. 14
    Michael S. Gordon, Timothy W. Kinlock, Robert P. Schwartz, Kevin E. O’Grady, A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release, Addiction, 2008, 103, 8
  15. 15
    David M. Novick, Mary Jeanne Kreek, Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients, Addiction, 2008, 103, 6
  16. 16
    Corrine E. Munoz-Plaza, Shiela Strauss, Janetta Astone-Twerell, Don Des Jarlais, Marya Gwadz, Holly Hagan, Andrew Osborne, Andrew Rosenblum, Exploring drug users’ attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S., International Journal of Drug Policy, 2008, 19, 1, 71

    CrossRef

  17. 17
    Curtis L. Cooper, Obstacles to Successful HCV Treatment in Substance Addicted Patients, Journal of Addictive Diseases, 2008, 27, 2, 61

    CrossRef

  18. 18
    Carrie Reed, Sherri O. Stuver, Sheila Tumilty, David Nunes, Jessica E. Murray, Camilla S. Graham, Margaret James Koziel, Donald E. Craven, Paul R. Skolnik, C. Robert Horsburgh, Predictors of Treatment for Hepatitis C Virus (HCV) Infection in Drug Users, Substance Abuse, 2008, 29, 1, 5

    CrossRef

  19. 19
    Timothy W. Kinlock, Michael S. Gordon, Robert P. Schwartz, Kevin O’Grady, Terrence T. Fitzgerald, Monique Wilson, A randomized clinical trial of methadone maintenance for prisoners: Results at 1-month post-release, Drug and Alcohol Dependence, 2007, 91, 2-3, 220

    CrossRef

  20. 20
    Diana L. Sylvestre, Barry J. Clements, Adherence to hepatitis C treatment in recovering heroin users maintained on methadone, European Journal of Gastroenterology & Hepatology, 2007, 19, 9, 741

    CrossRef

  21. 21
    Vincenzo Guadagnino, Maria Paola Trotta, Franco Montesano, Sergio Babudieri, Benedetto Caroleo, Orlando Armignacco, Jessica Carioti, Giuseppe Maio, Roberto Monarca, Andrea Antinori, Effectiveness of a multi-disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmes, Addiction, 2007, 102, 3
  22. 22
    Gregory J. Dore, Enhancing hepatitis C treatment uptake and outcomes for injection drug users, Hepatology, 2007, 45, 1
  23. 23
    Greg Scott, Sandra D. Thomas, Harold A. Pollack, Bradley Ray, Observed Patterns of Illicit Opiate Overdose Deaths in Chicago, 1999–2003, Journal of Urban Health, 2007, 84, 2, 292

    CrossRef

  24. 24
    Oanh K. Nguyen, Gregory J. Dore, John M. Kaldor, Margaret E. Hellard, Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: Insights from the ATAHC study, International Journal of Drug Policy, 2007, 18, 5, 447

    CrossRef

  25. 25
    Amrita Sethi, Mitchell L. Shiffman, Approach to the Management of Patients with Chronic Hepatitis C Who Failed to Achieve Sustained Virologic Response, Infectious Disease Clinics of North America, 2006, 20, 1, 115

    CrossRef

  26. 26
    David Nunes, Richard Saitz, Howard Libman, Debbie M. Cheng, John Vidaver, Jeffrey H. Samet, Barriers to Treatment of Hepatitis C in HIV/HCV-Coinfected Adults with Alcohol Problems, Alcoholism: Clinical and Experimental Research, 2006, 30, 9
  27. 27
    Andrés Ruiz-Sancho, Vicente Soriano, Coinfección por el VIH y el virus de la hepatitis C, Enfermedades Infecciosas y Microbiología Clínica, 2006, 24, 5, 335

    CrossRef

  28. 28
    Jennifer V. Campbell, Holly Hagan, Mary H. Latka, Richard S. Garfein, Elizabeth T. Golub, Micaela H. Coady, David L. Thomas, Steffanie A. Strathdee, High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities, Drug and Alcohol Dependence, 2006, 81, 3, 259

    CrossRef

  29. 29
    B. R. Edlin, M. R. Carden, Injection Drug Users: The Overlooked Core of the Hepatitis C Epidemic, Clinical Infectious Diseases, 2006, 42, 5, 673

    CrossRef

  30. 30
    Keyur Patel, Is compliance with antiviral therapy for chronic hepatitis C lower in intravenous drug users?, Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3, 7, 368

    CrossRef

  31. 31
    Pablo Saiz De La Hoya-Zamácola, Andrés Marco-Mouriño, Gerardo Clemente-Ricote, Joaquín Portilla-Sogorb, Vicente Boix-Martínez, Óscar Núñez-Martínez, Sergio Reus-Bañuls, Nuria Teixidó i Pérez, Recomendaciones de expertos sobre el diagnóstico y tratamiento de la hepatitis C crónica en el medio penitenciario, Enfermedades Infecciosas y Microbiología Clínica, 2006, 24, 9, 568

    CrossRef

  32. 32
    Pablo Saiz de la Hoya-Zamácola, Andrés Marco-Mouriño, Gerardo Clemente-Ricote, Joaquín Portilla-Sogorb, Vicente Boix-Martínez, Óscar Núñez-Martínez, Sergio Reus-Bañuls, Nuria Teixidó i Pérez, Recomendaciones de expertos sobre el diagnóstico y tratamiento de la hepatitis C crónica en el medio penitenciario, Gastroenterología y Hepatología, 2006, 29, 9, 551

    CrossRef

  33. 33
    Çetin Karaca, Yilmaz Çakaloğlu, Kadir Demir, Sadakat Özdil, Sabahattin Kaymakoğlu, Selim Badur, Atilla Ökten, Risk Factors for the Transmission of Hepatitis C Virus Infection in the Turkish Population, Digestive Diseases and Sciences, 2006, 51, 2, 365

    CrossRef

  34. 34
    Matthew L Cowan, James D Maxwell, Treatment of hepatitis C virus infection in intravenous drug users, Acta Neuropsychiatrica, 2006, 18, 5
  35. 35
    Shiela M. Strauss, David M. Rindskopf, Janetta M. Astone-Twerell, Don C. Des Jarlais, Holly Hagan, Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S., Drug and Alcohol Dependence, 2006, 83, 1, 15

    CrossRef

  36. 36
    B. Conway, J. Grebely, H. Tossonian, D. Lefebvre, S. Vlaming de, A Systematic Approach to the Treatment of HIV and Hepatitis C Virus Infection in the Inner City: A Canadian Perspective, Clinical Infectious Diseases, 2005, 41, Supplement 1, S73

    CrossRef

  37. 37
    B. Fischer, S. Vasdev, E. Haydon, D. Baliunas, J. Rehm, Acceptabilité d’un traitement du virus de l’hépatite C chez des utilisateurs de drogues injectables au Canada, La Presse Médicale, 2005, 34, 17, 1209

    CrossRef

  38. 38
    Amrita Sethi, Mitchell L. Shiffman, Approach to the Management of Patients with Chronic Hepatitis C Who Failed to Achieve Sustained Virologic Response, Clinics in Liver Disease, 2005, 9, 3, 453

    CrossRef

  39. 39
    Lynn E. Taylor, Delivering Care to Injection Drug Users Coinfected with HIV and Hepatitis C Virus, Clinical Infectious Diseases, 2005, 40, s5, S355

    CrossRef

  40. 40
    Jens Reimer, Bernd Schulte, Xavier Castells, Ingo Schafer, Susanne Polywka, Dagmar Hedrich, Lucas Wiessing, Christian Haasen, Markus Backmund, Michael Krausz, Guidelines for the Treatment of Hepatitis C Virus Infection in Injection Drug Users: Status Quo in the European Union Countries, Clinical Infectious Diseases, 2005, 40, s5, S373

    CrossRef

  41. 41
    Glenn J Wagner, Gery W Ryan, Hepatitis C virus treatment decision-making in the context of HIV co-infection: the role of medical, behavioral and mental health factors in assessing treatment readiness, AIDS, 2005, 19, Suppl 3, S190

    CrossRef

  42. 42
    Mark L Willenbring, Integrating care for patients with infectious, psychiatric, and substance use disorders: concepts and approaches, AIDS, 2005, 19, Suppl 3, S227

    CrossRef

  43. 43
    Shiela M. Strauss, Janetta M. Astone, Don C. Des Jarlais, Holly Hagan, Integrating Hepatitis C Services into Existing HIV Services: The Experiences of a Sample of U.S. Drug Treatment Units, AIDS Patient Care and STDs, 2005, 19, 2, 78

    CrossRef

  44. 44
    Anna Doab, Carla Treloar, Gregory J. Dore, Knowledge and Attitudes about Treatment for Hepatitis C Virus Infection and Barriers to Treatment among Current Injection Drug Users in Australia, Clinical Infectious Diseases, 2005, 40, s5, S313

    CrossRef

  45. 45
    Robert G. Gish, Nezam H. Afdhal, Douglas T. Dieterich, K. Rajender Reddy, Management of hepatitis C virus in special populations: Patient and treatment considerations, Clinical Gastroenterology and Hepatology, 2005, 3, 4, 311

    CrossRef

  46. 46
    Joy C. Draper, Elinore F. McCance-Katz, Medical Illness and Comorbidities in Drug Users: Implications for Addiction Pharmacotherapy Treatment, Substance Use & Misuse, 2005, 40, 13-14, 1899

    CrossRef

  47. 47
    Vincent Soriano, Luz Martin-Carbonero, Ivana Maida, Javier Garcia-Samaniego, Marina Nuñez, New paradigms in the management of HIV and hepatitis C virus coinfection, Current Opinion in Infectious Diseases, 2005, 18, 6, 550

    CrossRef

  48. 48
    Brian R. Edlin, Thomas F. Kresina, Daniel B. Raymond, Michael R. Carden, Marc N. Gourevitch, Josiah D. Rich, Laura W. Cheever, Victoria A. Cargill, Overcoming Barriers to Prevention, Care, and Treatment of Hepatitis C in Illicit Drug Users, Clinical Infectious Diseases, 2005, 40, s5, S276

    CrossRef

  49. 49
    Vanessa V Thompson, Kathleen E Ragland, Christopher S Hall, Maureen Morgan, David R Bangsberg, Provider assessment of eligibility for hepatitis C treatment in HIV-infected homeless and marginally housed persons, AIDS, 2005, 19, Suppl 3, S208

    CrossRef

  50. 50
    Janetta M. Astone, Shiela M. Strauss, Corrine Munoz-Plaza, Holly Hagan, Don C. Des Jarlais, Providing Support to Drug Users Infected with Hepatitis C, Journal of Maintenance in the Addictions, 2005, 3, 1, 33

    CrossRef

  51. 51
    Diana L. Sylvestre, Alain H. Litwin, Barry J. Clements, Marc N. Gourevitch, The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone, Journal of Substance Abuse Treatment, 2005, 29, 3, 159

    CrossRef

  52. 52
    M.A. Stoové, S.M. Gifford, G.J. Dore, The impact of injecting drug use status on hepatitis C-related referral and treatment, Drug and Alcohol Dependence, 2005, 77, 1, 81

    CrossRef

  53. 53
    Curtis L Cooper, Therapies for HIV and viral hepatitis coinfection, Expert Review of Anti-infective Therapy, 2005, 3, 1, 81

    CrossRef

  54. 54
    Gail Matthews, Ian J. Kronborg, Gregory J. Dore, Treatment for Hepatitis C Virus Infection among Current Injection Drug Users in Australia, Clinical Infectious Diseases, 2005, 40, s5, S325

    CrossRef

  55. 55
    Mark Evans, Angela L. Stotts, Susan Graham, Joy Schmitz, John Grabowski, Hepatitis C Knowledge Assessment and Counseling Within the Context of Substance Abuse Treatment, Addictive Disorders & Their Treatment, 2004, 3, 1, 18

    CrossRef

  56. 56
    Brian R. Edlin, Hepatitis C prevention and treatment for substance users in the United States: acknowledging the elephant in the living room, International Journal of Drug Policy, 2004, 15, 2, 81

    CrossRef

  57. 57
    M. Backmund, K. Meyer, B. R. Edlin, Infrequent Reinfection after Successful Treatment for Hepatitis C Virus Infection in Injection Drug Users, Clinical Infectious Diseases, 2004, 39, 10, 1540

    CrossRef

  58. 58
    Martin Schaefer, Andreas Heinz, Markus Backmund, Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?, Addiction, 2004, 99, 9
  59. 59
    CATHERINE CRONE, GEOFFREY M. GABRIEL, Comprehensive Review of Hepatitis C for Psychiatrists: Risks, Screening, Diagnosis, Treatment, and Interferon-Based Therapy Complications, Journal of Psychiatric Practice, 2003, 9, 2, 93

    CrossRef

  60. 60
    Jean-Michel Pawlotsky, Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C, Antiviral Research, 2003, 59, 1, 1

    CrossRef

  61. 61
    Jean-Michel Pawlotsky, The nature of interferon-?? resistance in hepatitis C virus infection, Current Opinion in Infectious Diseases, 2003, 16, 6, 587

    CrossRef